Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

  1. Afonso, F.J.
  2. Anido, U.
  3. Fernández-Calvo, O.
  4. Vázquez-Estévez, S.
  5. León, L.
  6. Lázaro, M.
  7. Ramos, M.
  8. Antón-Aparicio, L.
Journal:
Clinical and Translational Oncology

ISSN: 1699-3055,  1699-048X

Year of publication: 2013

Volume: 15

Issue: 6

Pages: 425-433

Type: Article

DOI: 10.1007/S12094-012-0985-X GOOGLE SCHOLAR
Data source: Scopus